Rareco CV 500 is the combination of cefuroxime axetil and potassium clavulanate in a single tablet is often prescribed to treat infections caused by bacteria that may be resistant to antibiotics.
Rareco CV 500: Powerhouse Duo Against Bacterial Infections
Rareco CV 500 combines the strengths of Cefuroxime Axetil and Potassium Clavulanate in one convenient tablet to effectively combat a broad spectrum of bacterial infections, especially those resistant to other antibiotics.
Here’s a look at how Rareco CV 500 works:
Cefuroxime Axetil: This broad-spectrum cephalosporin antibiotic disrupts bacterial cell wall formation, hindering their growth and leading to their death.
Potassium Clavulanate: This beta-lactamase inhibitor acts like a bodyguard for cefuroxime axetil. It protects the antibiotic from being broken down by beta-lactamase enzymes produced by certain bacteria, ensuring cefuroxime axetil’s effectiveness against strains resistant to other antibiotics.
Why Choose Rareco CV 500?
Combats Resistant Bacteria: Rareco CV 500 effectively tackles infections caused by bacteria resistant to other antibiotics due to beta-lactamase production.
Versatile Treatment: This medication is effective against a wide range of bacterial infections, making it a suitable choice for various conditions.
Convenient Dosing: Get the benefits of both antibiotic and its protector in one convenient tablet, simplifying your treatment regimen.
Important Information:
Always take Rareco CV 500 under a doctor’s supervision.
Inform your doctor about any allergies, pre-existing medical conditions, or medications you are taking.
Complete the prescribed dosage regimen even if symptoms improve, to prevent antibiotic resistance.
Disclaimer:
This information is intended for general knowledge only and should not be a substitute for professional medical advice. Always consult your doctor for diagnosis and treatment specific to your condition.
MFG By: Akums Lifesciences
MFG By: Akums Lifesciences
MFG By: Akums Lifesciences